PACB 2.3 (-6.12%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

53 / 58

Performance 5 years

38 / 58

Performance 10 years

39 / 58

Linearity 3 years

50 / 58

Linearity 5 years

9 / 58

Linearity 10 years

11 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Linearity 3 years - PACB ranking 50 / 58

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by linearity 3 years
1. Laboratory Corp of America Holdings LH
34.11
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Quest Diagnostics DGX
28.94
4. Waters WAT
21.85
5. Danaher DHR
20.68
6. PerkinElmer PKI
16.14
7. Thermo Fisher Scientific TMO
14.43
8. IQVIA Holdings IQV
13.6
9. Mettler-Toledo MTD
13.01
10. Agilent Technologies A
12.16
11. Syneos Health SYNH
10.68
12. Qiagen QGEN
10.11
13. Icon ICLR
8.22
14. Heska HSKA
7.67
15. Anixa Biosciences ANIX
6.87
16. Olink Holding OLK
6.67
17. Natera NTRA
5.97
18. IDEXX Laboratories IDXX
5.91
19. Sotera Health SHC
5.58
20. Myriad Genetics MYGN
4.43
21. Bioventus BVS
4.32
22. Global Cord Blood CO
4.22
23. Exact Sciences EXAS
4.13
24. Charles River Laboratories CRL
3.74
25. National Research NRC
3.72
26. DexCom DXCM
3.53
27. Sera Prognostics SERA
3.28
28. Illumina ILMN
2.75
29. Enzo Biochem ENZ
2.7
30. Medpace Holdings MEDP
2.58
31. CareDx CDNA
2.57
32. Psychemedics PMD
2.54
33. Neogen NEOG
2.5
34. NeoGenomics NEO
2.18
35. MDxHealth MDXH
2.14
36. MaxCyte MXCT
2.13
37. Fulgent Genetics FLGT
2.12
38. Trinity Biotech TRIB
2.07
39. Guardant Health GH
2.05
40. Twist Bioscience TWST
2.04
41. Interpace Biosciences IDXG
1.99
42. Neuronetics STIM
1.98
43. DarioHealth DRIO
1.79
44. Organovo Holdings ONVO
1.79
45. Exagen XGN
1.77
46. Co-Diagnostics CODX
1.73
47. bioAffinity Technologies BIAF
1.71
48. Precipio PRPO
1.71
49. Prenetics Global PRE
1.66
50. Pacific Biosciences of California PACB
1.65
51. Biodesix BDSX
1.61
52. Personalis PSNL
1.58
53. SeqLL SQL
1.48
54. Lantheus Holdings LNTH
1.45
55. Inotiv NOTV
1.43
56. Aspira Womens Health AWH
1.38
57. Meridian Bioscience VIVO
0.73
58. RadNet RDNT
0.64
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.